Man Group’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-11,600
Closed -$2.13M 2063
2021
Q2
$2.13M Sell
11,600
-41,186
-78% -$7.57M 0.01% 1203
2021
Q1
$8.07M Sell
52,786
-812,208
-94% -$124M 0.04% 500
2020
Q4
$135M Sell
864,994
-500,900
-37% -$78.3M 0.59% 20
2020
Q3
$156M Buy
1,365,894
+826,091
+153% +$94.5M 0.62% 22
2020
Q2
$60.6M Buy
539,803
+53,815
+11% +$6.04M 0.31% 65
2020
Q1
$43.6M Sell
485,988
-351,065
-42% -$31.5M 0.28% 76
2019
Q4
$90.5M Buy
837,053
+323,949
+63% +$35M 0.3% 63
2019
Q3
$50.3M Buy
513,104
+398,394
+347% +$39M 0.19% 114
2019
Q2
$15M Buy
114,710
+91,528
+395% +$12M 0.05% 446
2019
Q1
$3.13M Sell
23,182
-83,180
-78% -$11.2M 0.01% 1139
2018
Q4
$10.4M Sell
106,362
-11,539
-10% -$1.12M 0.05% 438
2018
Q3
$16.4M Buy
117,901
+41,610
+55% +$5.78M 0.06% 388
2018
Q2
$9.47M Sell
76,291
-47,784
-39% -$5.93M 0.04% 602
2018
Q1
$13.8M Buy
+124,075
New +$13.8M 0.06% 342